Reversal of GABA-mediated inhibition of the electrically and potassium chloride evoked [H-3]-GABA release from rat substantia nigra slices by DL-3-hydroxy-3-phenyl pentanamide

SE Meza-Toledo, Norman Bowery

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The phenyl alcohol amides, DL-2-hydroxy-2-phenyl butyramide (CAS 52839-87-9), DL-3-hydroxy-3-phenyl pentanamide (CAS 131802-69-2, DL-HEPP) and DL-4-hydroxy-4-phenyl hexanamide (CAS 67880-30-2) and their fluorine and chlorine analogs, at a concentration of 100 mu mol/L, did not displace [H-3]-gamma-aminobutyric acid ([H-3]-GABA, CAS 108158-36-7) from GABA(A) receptors and only weakly displaced [H-3]-GABA and [H-3]-CGP62349 (CAS 186986-97-0), a GABA(B) receptor antagonist, from GABAB receptors in rat brain crude synaptic membranes. The electrically and potassium chloride (15 mmol/L) evoked [H-3]GABA release in the presence of DL-HEPP, GABA and GABAB receptor ligands from rat brain substantia nigra (SN) slices was studied. R-Baclofen (CAS 69308-37-8) (10 mu mol/L), a GABA(B) receptor agonist, produced an inhibition of the electrically evoked [H-3]-GABA release and this inhibition was blocked by CGP 55845A (CAS 149184-22-5) (10 mu mol/L), a GABA(B) receptor antagonist, but was not affected by DL-HEPP (100 mu mol/L). CGP 55845A (10 mu mol/L) did not alter the electrically evoked [H-3]-GABA release in the absence of baclofen. The addition of DL-HEPP (100 mu mol/L) alone did not affect the electrically-evoked release of [H-3]-GABA release control, but it was able to significantly. reduce the inhibitory effect of GABA (CAS 56-12-2) (10 mu mol/L) on [H-3]-GABA release evoked both by electrical and potassium chloride stimulation, in the presence of tiagabine (CAS 115103-54-3) (10 mu mol/L), a GABA uptake blocker. In three preliminary experiments, bicuculline (CAS 485-49-4) (10 mu mol/L) and picrotoxinin (CAS 17617-45-7) (10 mu mol/L), two GABA(A) antagonists, inhibited the electrically evoked release of [H-3]-GABA from rat SN slices, and DL-HEPP (100 mu mol/L) reversed this inhibition. The mechanism of action of DL-HEPP is not known but, it might act as a negative GABA modulator in rat brain slices.
Original languageEnglish
Pages (from-to)53-61
Number of pages9
JournalArzneimittel-Forschung
Volume58
Issue number2
Publication statusPublished - 1 Jan 2008

Keywords

  • anticonvulsants
  • substantia nigra, evoked [H-3]-GABA release
  • DL-3-hydroxy-3-phenyl pentanamide, influence on GABA binding
  • GABA modulators, negative

Fingerprint

Dive into the research topics of 'Reversal of GABA-mediated inhibition of the electrically and potassium chloride evoked [H-3]-GABA release from rat substantia nigra slices by DL-3-hydroxy-3-phenyl pentanamide'. Together they form a unique fingerprint.

Cite this